CUSTOM V

Our CUSTOM V pivotal clinical trial will be designed to generate additional data supporting specific claims that could be used to support marketing approvals or to seek reimbursement in selected European countries. We believe this clinical trial will be a prospective, controlled trial that will include up to approximately 1,000 CAD patients. We expect to initiate CUSTOM V in 2008.